| Year |
Citation |
Score |
| 2022 |
Wardak M, Sonni I, Fan AP, Minamimoto R, Jamali M, Hatami N, Zaharchuk G, Fischbein N, Nagpal S, Li G, Koglin N, Berndt M, Bullich S, Stephens AW, Dinkelborg LM, et al. F-FSPG PET/CT Imaging of System x Transporter Activity in Patients with Primary and Metastatic Brain Tumors. Radiology. 203296. PMID 35191738 DOI: 10.1148/radiol.203296 |
0.331 |
|
| 2018 |
Zhang W, Bouchard G, Yu A, Shafiq M, Jamali M, Shrager JB, Ayers K, Bakr S, Gentles AJ, Diehn M, Quon A, West RB, Nair V, van de Rijn M, Napel S, et al. GFPT2-expressing cancer-associated fibroblasts mediate metabolic reprogramming in human lung adenocarcinoma. Cancer Research. PMID 29760045 DOI: 10.1158/0008-5472.Can-17-2928 |
0.423 |
|
| 2017 |
Minamimoto R, Jamali M, Gevaert O, Echegaray S, Khuong A, Hoang CD, Shrager JB, Plevritis SK, Rubin DL, Leung AN, Napel S, Quon A. Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative (18)F FDG-PET/CT metrics. Oncotarget. 8: 52792-52801. PMID 28881771 DOI: 10.18632/Oncotarget.17782 |
0.446 |
|
| 2017 |
Minamimoto R, Xu G, Jamali M, Holley D, Barkhodari A, Zaharchuk G, Iagaru A. Semiquantitative Assessment of (18)F-FDG Uptake in the Normal Skeleton: Comparison Between PET/CT and Time-of-Flight Simultaneous PET/MRI. Ajr. American Journal of Roentgenology. 1-7. PMID 28777652 DOI: 10.2214/Ajr.17.18044 |
0.397 |
|
| 2017 |
Minamimoto R, Jamali M, Gevaert O, Echegaray S, Khuong A, Hoang CD, Shrager JB, Plevritis SK, Rubin DL, Leung AN, Napel S, Quon A. Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative 18F FDG-PET/CT metrics. Oncotarget. PMID 28538213 DOI: 10.18632/oncotarget.17782 |
0.347 |
|
| 2017 |
Hanneman K, Kadoch M, Guo HH, Jamali M, Quon A, Iagaru A, Herfkens R. Initial Experience With Simultaneous 18F-FDG PET/MRI in the Evaluation of Cardiac Sarcoidosis and Myocarditis. Clinical Nuclear Medicine. PMID 28418949 DOI: 10.1097/Rlu.0000000000001669 |
0.374 |
|
| 2017 |
Minamimoto R, Iagaru A, Jamali M, Holley D, Barkhodari A, Vasanawala S, Zaharchuk G. Conspicuity of Malignant Lesions on PET/CT and Simultaneous Time-Of-Flight PET/MRI. Plos One. 12: e0167262. PMID 28103230 DOI: 10.1371/Journal.Pone.0167262 |
0.375 |
|
| 2017 |
Zhang W, Bouchard G, Yu A, Shafiq M, Jamali M, Shrager J, Ayers K, Nair VS, Gentles A, Diehn M, Quon A, Napel S, Plevritis S. Abstract 4403: FDG uptake in human lung adenocarcinoma associated with invasion through the hexosamine biosynthesis pathway Cancer Research. 77: 4403-4403. DOI: 10.1158/1538-7445.Am2017-4403 |
0.38 |
|
| 2016 |
Park SM, Wong DJ, Ooi CC, Kurtz DM, Vermesh O, Aalipour A, Suh S, Pian KL, Chabon JJ, Lee SH, Jamali M, Say C, Carter JN, Lee LP, Kuschner WG, et al. Molecular profiling of single circulating tumor cells from lung cancer patients. Proceedings of the National Academy of Sciences of the United States of America. PMID 27956614 DOI: 10.1073/Pnas.1608461113 |
0.649 |
|
| 2016 |
Thompson HM, Minamimoto R, Jamali M, Barkhodari A, von Eyben R, Iagaru A. A Prospective, Matched Comparison Study of SUV Measurements From Time-of-Flight Versus Non-Time-of-Flight PET/CT Scanners. Clinical Nuclear Medicine. PMID 26914563 DOI: 10.1097/Rlu.0000000000001170 |
0.401 |
|
| 2016 |
Minamimoto R, Levin C, Jamali M, Holley D, Barkhodari A, Zaharchuk G, Iagaru A. Improvements in PET Image Quality in Time of Flight (TOF) Simultaneous PET/MRI. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 26884058 DOI: 10.1007/S11307-016-0939-8 |
0.39 |
|
| 2015 |
Iagaru A, Minamimoto R, Levin C, Barkhodari A, Jamali M, Holley D, Greg Z. The potential of TOF PET-MRI for reducing artifacts in PET images. Ejnmmi Physics. 2: A77. PMID 26956338 DOI: 10.1186/2197-7364-2-S1-A77 |
0.391 |
|
| 2015 |
Iagaru A, Minamimoto R, Jamali M, Barkodhodari A, Gambhir SS, Vasanawala S. Imaging patients with breast and prostate cancers using combined 18F NaF/18F FDG and TOF simultaneous PET/ MRI. Ejnmmi Physics. 2: A65. PMID 26956325 DOI: 10.1186/2197-7364-2-S1-A65 |
0.577 |
|
| 2015 |
Minamimoto R, Iagaru A, Jamali M, Barkodhodari A, Holley D, Vasanawala S, Zaharchuk G. Whole-body simultaneous time-of-flight PET-MRI: early experience with clinical studies. Ejnmmi Physics. 2: A64. PMID 26956324 DOI: 10.1186/2197-7364-2-S1-A64 |
0.397 |
|
| 2015 |
Moradi F, Jamali M, Barkhodari A, Schneider B, Chin F, Quon A, Mittra ES, Iagaru A. Spectrum of 68Ga-DOTA TATE Uptake in Patients With Neuroendocrine Tumors. Clinical Nuclear Medicine. PMID 26673240 DOI: 10.1097/Rlu.0000000000001100 |
0.359 |
|
| 2015 |
Minamimoto R, Hancock S, Schneider B, Chin F, Jamali M, Loening AM, Vasanawala S, Gambhir SS, Iagaru A. Pilot Comparison of 68Ga-RM2 PET and 68Ga-PSMA PET in Patients with Biochemically Recurrent Prostate Cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26659347 DOI: 10.2967/Jnumed.115.168393 |
0.672 |
|
| 2015 |
Minamimoto R, Karam A, Jamali M, Barkhodari A, Gambhir SS, Dorigo O, Iagaru A. Pilot prospective evaluation of (18)F-FPPRGD2 PET/CT in patients with cervical and ovarian cancer. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26611425 DOI: 10.1007/S00259-015-3263-7 |
0.595 |
|
| 2015 |
Minamimoto R, Loening A, Jamali M, Barkhodari A, Mosci C, Jackson T, Obara P, Taviani V, Gambhir SS, Vasanawala S, Iagaru AH. Prospective Comparison of 99mTc MDP Scintigraphy, Combined 18F-NaF and 18F-FDG PET/CT and Whole-Body MRI in Patients with Breast and Prostate Cancers. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26405167 DOI: 10.2967/Jnumed.115.162610 |
0.693 |
|
| 2015 |
Minamimoto R, Jamali M, Barkhodari A, Mosci C, Mittra E, Shen B, Chin F, Gambhir SS, Iagaru A. Biodistribution of the (18)F-FPPRGD 2 PET radiopharmaceutical in cancer patients: an atlas of SUV measurements. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26062933 DOI: 10.1007/S00259-015-3096-4 |
0.567 |
|
| 2015 |
Minamimoto R, Mosci C, Jamali M, Barkhodari A, Habte F, Jackson T, Mittra E, Gambhir SS, Iagaru A. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 688-94. PMID 25840978 DOI: 10.2967/Jnumed.115.153767 |
0.498 |
|
| 2015 |
Sabbah N, Jackson T, Mosci C, Jamali M, Minamimoto R, Quon A, Mittra ES, Iagaru A. 18F-sodium fluoride PET/CT in oncology: an atlas of SUVs. Clinical Nuclear Medicine. 40: e228-31. PMID 25546225 DOI: 10.1097/Rlu.0000000000000633 |
0.376 |
|
| 2015 |
Iagaru A, Mittra E, Minamimoto R, Jamali M, Levin C, Quon A, Gold G, Herfkens R, Vasanawala S, Gambhir SS, Zaharchuk G. Simultaneous whole-body time-of-flight 18F-FDG PET/MRI: a pilot study comparing SUVmax with PET/CT and assessment of MR image quality. Clinical Nuclear Medicine. 40: 1-8. PMID 25489952 DOI: 10.1097/Rlu.0000000000000611 |
0.518 |
|
| 2014 |
Carlsson A, Nair VS, Luttgen MS, Keu KV, Horng G, Vasanawala M, Kolatkar A, Jamali M, Iagaru AH, Kuschner W, Loo BW, Shrager JB, Bethel K, Hoh CK, Bazhenova L, et al. Circulating tumor microemboli diagnostics for patients with non-small-cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 9: 1111-9. PMID 25157764 DOI: 10.1097/Jto.0000000000000235 |
0.714 |
|
| 2014 |
Nair VS, Giraldez M, Luttgen M, Keu KV, Vasanawala M, Horng G, Jamali M, Kolatkar A, Kuschner W, Kuhn P, Gambhir SS, Tewari M. Abstract 4006: MicroRNA footprints of circulating tumor cells in patients with non-small cell lung cancer Cancer Research. 74: 4006-4006. DOI: 10.1158/1538-7445.Am2014-4006 |
0.685 |
|
| Show low-probability matches. |